Evidence map›Paper›PMID 10878069›Full record

Trial reportJournal of clinical microbiology2000

Comparison of sequencing by hybridization and cycle sequencing for genotyping of human immunodeficiency virus type 1 reverse transcriptase.

G J Hanna, V A Johnson, D R Kuritzkes, D D Richman, J Martinez-Picado, L Sutton, J D Hazelwood, R T D'Aquila

Open access · bronzeAbstract readClinical TrialComparative StudyRandomized Controlled Trial
In one paragraph

Trial report in Journal of clinical microbiology, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 39 citations in OpenAlex.

  1. Overview of Next-Generation Sequencing Technologies.Current protocols in molecular biology · 2018
    Review
  2. Article
  3. Article
  4. Article
  5. A role for arrays in clinical virology: fact or fiction?Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology · 2004
    Review
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

G J HannaMassachusetts General Hospital, Boston, Massachusetts 02129, USA.
V A Johnson
D R Kuritzkes
D D Richman
J Martinez-Picado
L Sutton
J D Hazelwood
R T D'Aquila
Harvard University · USMassachusetts General Hospital · USUniversity of Alabama at Birmingham · USUniversity of Colorado Health · US

Funding

WOMEN'S HEALTH AGENDAU01AI038858 · NIAID · SOCIAL AND SCIENTIFIC SYSTEMS, INC. · PI BENSON, CONSTANCE ANN · 1996 to 2008
$157.5M
Virology CoreP30AI027767 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Paul A. Goepfert · 1988 to 2026
$84.1M
VirologyP30AI036214 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SUSAN JANET LITTLE · 1994 to 2026
$78.4M
ZOPOLRESTAT PHARMACOKINETICS IN DIABETICS WITH VARYING RENAL FUNCTIONM01RR000051 · NCRR · UNIVERSITY OF COLORADO DENVER · PI WALDERS, NATALIE · 1985 to 2008
$52.6M
WOMEN'S HEALTH AGENDAU01AI027670 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BENSON, CONSTANCE ANN · 1988 to 2006
$13.7M
WOMEN'S HEALTH AGENDAU01AI032775 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SAAG, MICHAEL S. · 1992 to 2007
$12.9M
WOMEN'S HEALTH AGENDAU01AI027659 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI KURITZKES, DANIEL R · 1988 to 2006
$11.8M
WOMEN'S HEALTH AGENDAU01AI032770 · NIAID · UNIVERSITY OF COLORADO DENVER · PI CAMPBELL, THOMAS B. · 1992 to 2006
$11.8M
Multidisciplinary HIV Training ProgramT32AI007387 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI Daniel R. Kuritzkes · 1990 to 2026
$8.8M
NUCLEOSIDE RESISTANCE OF THE HIV-1 REVERSE TRANSCRIPTASER01AI029193 · NIAID · VANDERBILT UNIVERSITY · PI D'AQUILA, RICHARD T · 1990 to 2007
$2.8M
ANTIVIRAL RESISTANCE IN AIDSR37AI029164 · NIAID · UNIVERSITY OF CALIFORNIA SAN DIEGO · PI RICHMAN, DOUGLAS D · 1994 to 2004
$2.0M
HIV-1 resistance to nucleoside analoguesR01AI042567 · NIAID · UNIVERSITY OF COLORADO DENVER · PI KURITZKES, DANIEL R · 1998 to 2004
$1.7M
NCRR NIH HHS M01 RR000051NIAID NIH HHS AI01696NIAID NIH HHS AI07387NIAID NIH HHS AI29193NIAID NIH HHS P30 AI027767NIAID NIH HHS P30 AI036214NIAID NIH HHS R01 AI029193NIAID NIH HHS R01 AI042567NIAID NIH HHS R37 AI029164NIAID NIH HHS T32 AI007387NIAID NIH HHS U01 AI027659NIAID NIH HHS U01 AI027670NIAID NIH HHS U01 AI032770NIAID NIH HHS U01 AI032775NIAID NIH HHS U01 AI038858
6 · The paper itself

Abstract

The performances of two methods of nucleotide sequencing were compared for the detection of drug resistance mutations in human immunodeficiency virus type 1 reverse transcriptase (RT) in viruses isolated from highly RT inhibitor-experienced individuals. Of 11,677 amino acids deduced from population PCR products by both cycle sequencing and sequencing by hybridization to high-density arrays of oligonucleotide probes, 97.4% were concordant by both methods, 0.8% were discordant, and 1.7% had an ambiguous determination by at least one method. A higher rate of discordance (3.9%) was observed among RT inhibitor resistance-associated codons. In 45% of the isolates, RT codon 67 was deduced as the wild-type Asp by hybridization sequencing but as the zidovudine resistance-associated Asn by cycle sequencing. In other resistance-associated codon discordances, cycle sequencing also more commonly called a known resistance-associated amino acid than hybridization sequencing did. The nucleotide sequence in the vicinity of several codons with discordant calls influenced population-based hybridization sequencing. For isolates evaluated by additional sequencing of molecular clones of PCR products by both methods, the discordance between methods was less frequent (0.4% of all 5,994 amino acids and 0 of 494 drug resistance-associated codons). At positions which were discordant or ambiguous in the population sequences, the results of sequencing of clones by both methods were usually in agreement with the population cycle sequencing result. In summary, most RT codons were highly concordant by both methods of population-based sequencing, with discordances due in large part to genetic mixtures within or adjacent to discordant codons.

Indexed as

Anti-HIV AgentsCodonDouble-Blind MethodDrug Resistance, MicrobialGenotypeHIV-1HIV InfectionsHIV Reverse TranscriptaseHumansMolecular Sequence DataNucleic Acid HybridizationPolymerase Chain ReactionReverse Transcriptase InhibitorsSequence Analysis, DNAAnti-HIV AgentsCodonHIV Reverse TranscriptaseReverse Transcriptase Inhibitors

Identifiers

PMID10878069
PMCPMC87006
OpenAlexW2131655691

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.